@inproceedings{inproceedings, title  = {{Putative Predictors of Response to WU-NK-101, an Allogeneic, Enhanced Memory (ML) Natural Killer (NK) Cell Therapy Product, for Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)}},

 publisher = {{American Society of Hematology}},

 url = {{https://doi.org/10.1182/blood-2022-157199 }},

 year = {{2022}},

 month = {{11}},

 author = {{Rutella S and Cashen AF and Muth J and Mathyer ME and Carter AJ and Tumala B and Arthur L and Magee K and Comune Pennacchi P and Gorrochategui J and Petit V et al}},

 doi = {{10.1182/blood-2022-157199}},

 volume = {{140}},

 journal = {{Blood}},

 issue = {{Supplement 1}},

 pages = {{7400-7401}},

 note = {{Accessed on 2026/02/25}}}